In just one day, BD associates help non-profits solve real operational challenges, delivering everything from strategy and communications plans to AI-driven tools, frameworks and measurable outcomes.
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
Q4 revenue of $5.3 billion increased 5.4% as reported, 5.6% FXN Q4 GAAP and adjusted diluted EPS of $2.52 and $4.15, respectively FY26 revenue of $19.5 billion increased 4.9% as reported, 3.9% FXN...
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has declared a quarterly dividend of $1.06 per common share, an increase of...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral...
By Emily Moulton, National Clinical Program Manager, Urology and Critical Care at BD, and Hannah Hinsley, Clinical Connect Program Specialist, Urology and Critical Care at BD In our work with...
Hearing directly from patients brings our purpose into focus and reminds us that the most meaningful innovations are those that help improve patient care and outcomes. By Tim Patz, Worldwide...
Helping patients and caregivers understand their options, ask the right questions, and take the next step with confidence can make a huge difference. By Mike Cusack, Worldwide President, BD...
